EU OKs Dune's next-gen breast cancer tissue assessment device

02/20/2013 | Boston Herald

Dune Medical Devices has obtained approval in Europe to market a next-generation version of its MarginProbe System console, a device used for intra-operative tissue evaluation during early-stage breast cancer procedures. The MarginProbe System Type 1.2 improves on the original model with a more compact size, better aesthetics and enhanced overall design.

View Full Article in:

Boston Herald

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD